VAV2 and prostate carcinoma: Silencing other PI3K-dependent Rac-GEFs expressed in prostate cancer cells, namely Tiam1, Vav2 or Vav3, also failed to reduce Rac1-GTP levels in PC3 cells (Figure 2A and Figure S1G).